ZA200609178B - (1,10B-dihydro-2-(aminocarbonyl-phenyl)-5H-pyrazolo[1,5-c][1,3]benzoxazin-5-yl)phenylmethanone derivatives as HIV viral replication inhibitors - Google Patents
(1,10B-dihydro-2-(aminocarbonyl-phenyl)-5H-pyrazolo[1,5-c][1,3]benzoxazin-5-yl)phenylmethanone derivatives as HIV viral replication inhibitorsInfo
- Publication number
- ZA200609178B ZA200609178B ZA200609178A ZA200609178A ZA200609178B ZA 200609178 B ZA200609178 B ZA 200609178B ZA 200609178 A ZA200609178 A ZA 200609178A ZA 200609178 A ZA200609178 A ZA 200609178A ZA 200609178 B ZA200609178 B ZA 200609178B
- Authority
- ZA
- South Africa
- Prior art keywords
- benzoxazin
- pyrazolo
- aminocarbonyl
- dihydro
- phenyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04101913 | 2004-05-04 | ||
US60427504P | 2004-08-25 | 2004-08-25 | |
PCT/EP2005/052041 WO2005105810A2 (en) | 2004-05-04 | 2005-05-04 | (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5- c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as hiv viral replication inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200609178B true ZA200609178B (en) | 2008-08-27 |
Family
ID=35058129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200609178A ZA200609178B (en) | 2004-05-04 | 2006-11-03 | (1,10B-dihydro-2-(aminocarbonyl-phenyl)-5H-pyrazolo[1,5-c][1,3]benzoxazin-5-yl)phenylmethanone derivatives as HIV viral replication inhibitors |
Country Status (20)
Country | Link |
---|---|
US (1) | US7326703B2 (no) |
EP (1) | EP1778696B1 (no) |
JP (1) | JP4929162B2 (no) |
KR (1) | KR20070015547A (no) |
CN (1) | CN1950380B (no) |
AP (1) | AP2006003759A0 (no) |
AR (1) | AR048650A1 (no) |
AT (1) | ATE389660T1 (no) |
AU (1) | AU2005238235B2 (no) |
BR (1) | BRPI0510612A (no) |
CA (1) | CA2563959C (no) |
DE (1) | DE602005005490T2 (no) |
ES (1) | ES2303244T3 (no) |
IL (1) | IL178082A (no) |
MX (1) | MXPA06012755A (no) |
NO (1) | NO20065582L (no) |
PL (1) | PL1778696T3 (no) |
RU (1) | RU2382789C2 (no) |
WO (1) | WO2005105810A2 (no) |
ZA (1) | ZA200609178B (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7122185B2 (en) | 2002-02-22 | 2006-10-17 | Progenics Pharmaceuticals, Inc. | Anti-CCR5 antibody |
TW200710091A (en) * | 2005-04-11 | 2007-03-16 | Tibotec Pharm Ltd | (1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors |
AU2006272750B2 (en) * | 2005-07-22 | 2011-09-29 | Cytodyn, Inc. | Methods for reducing viral load in HIV-1-infected patients |
US20100190809A1 (en) * | 2007-06-25 | 2010-07-29 | Jody Firmin Voorspoels | Combination formulations |
US8592487B2 (en) * | 2007-10-26 | 2013-11-26 | Concert Pharmaceuticals, Inc. | Deuterated darunavir |
WO2009134401A2 (en) * | 2008-04-29 | 2009-11-05 | Progenics Pharmaceuticals, Inc. | Methods of inhibiting infection by diverse subtypes of drug-resistant hiv-1 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
DE4210939A1 (de) * | 1992-04-02 | 1993-10-07 | Bayer Ag | Verwendung von 7-Oxo-7H-pyrido[1,2,3-de][1,4]benzoxacin-6-carbonsäuren und -estern als Arzneimittel |
PH30929A (en) | 1992-09-03 | 1997-12-23 | Janssen Pharmaceutica Nv | Beads having a core coated with an antifungal and a polymer. |
HU222355B1 (hu) | 1993-10-01 | 2003-06-28 | Astra Aktiebolag | Eljárás és berendezés finom gyógyszerhatóanyag-porok kezelésére és feldolgozására |
TR199801225T2 (xx) | 1996-05-20 | 1998-11-23 | Janssen Pharmaceutica N.V. | Geli�tirilmi� biyolojik kullan�l�rl��a sahip antifungal bile�imler. |
AU4802797A (en) | 1996-10-02 | 1998-04-24 | Du Pont Pharmaceuticals Company | 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv rever se transcriptase inhibitors and intermediates and processes for making the same |
RU2218153C2 (ru) | 1997-03-26 | 2003-12-10 | Жансен Фармасетика Н.В. | Драже, имеющее ядро, покрытое противогрибковым средством и полимером |
BR9815899A (pt) * | 1998-05-20 | 2001-02-20 | Lilly Co Eli | Compostos antivirais |
WO2002085860A1 (en) * | 2001-04-10 | 2002-10-31 | Pfizer Limited | Pyrazole derivatives for treating hiv |
-
2005
- 2005-05-03 AR ARP050101767A patent/AR048650A1/es unknown
- 2005-05-04 RU RU2006142705/04A patent/RU2382789C2/ru not_active IP Right Cessation
- 2005-05-04 JP JP2007512194A patent/JP4929162B2/ja not_active Expired - Fee Related
- 2005-05-04 AT AT05740229T patent/ATE389660T1/de not_active IP Right Cessation
- 2005-05-04 CA CA2563959A patent/CA2563959C/en not_active Expired - Fee Related
- 2005-05-04 US US11/568,380 patent/US7326703B2/en not_active Expired - Fee Related
- 2005-05-04 WO PCT/EP2005/052041 patent/WO2005105810A2/en active IP Right Grant
- 2005-05-04 DE DE602005005490T patent/DE602005005490T2/de active Active
- 2005-05-04 BR BRPI0510612-5A patent/BRPI0510612A/pt not_active IP Right Cessation
- 2005-05-04 KR KR1020067022005A patent/KR20070015547A/ko not_active Application Discontinuation
- 2005-05-04 MX MXPA06012755A patent/MXPA06012755A/es active IP Right Grant
- 2005-05-04 ES ES05740229T patent/ES2303244T3/es active Active
- 2005-05-04 EP EP05740229A patent/EP1778696B1/en active Active
- 2005-05-04 CN CN2005800140097A patent/CN1950380B/zh not_active Expired - Fee Related
- 2005-05-04 AP AP2006003759A patent/AP2006003759A0/xx unknown
- 2005-05-04 AU AU2005238235A patent/AU2005238235B2/en not_active Ceased
- 2005-05-04 PL PL05740229T patent/PL1778696T3/pl unknown
-
2006
- 2006-09-14 IL IL178082A patent/IL178082A/en not_active IP Right Cessation
- 2006-11-03 ZA ZA200609178A patent/ZA200609178B/xx unknown
- 2006-12-04 NO NO20065582A patent/NO20065582L/no unknown
Also Published As
Publication number | Publication date |
---|---|
US20070248624A1 (en) | 2007-10-25 |
AR048650A1 (es) | 2006-05-10 |
IL178082A (en) | 2012-06-28 |
US7326703B2 (en) | 2008-02-05 |
CN1950380A (zh) | 2007-04-18 |
ES2303244T3 (es) | 2008-08-01 |
WO2005105810A2 (en) | 2005-11-10 |
ATE389660T1 (de) | 2008-04-15 |
EP1778696B1 (en) | 2008-03-19 |
CA2563959A1 (en) | 2005-11-10 |
JP2007536346A (ja) | 2007-12-13 |
PL1778696T3 (pl) | 2008-08-29 |
IL178082A0 (en) | 2006-12-31 |
AU2005238235B2 (en) | 2011-07-07 |
KR20070015547A (ko) | 2007-02-05 |
CA2563959C (en) | 2014-07-15 |
AU2005238235A1 (en) | 2005-11-10 |
BRPI0510612A (pt) | 2007-10-30 |
NO20065582L (no) | 2006-12-04 |
AP2006003759A0 (en) | 2006-10-31 |
MXPA06012755A (es) | 2007-01-16 |
DE602005005490T2 (de) | 2009-04-23 |
RU2382789C2 (ru) | 2010-02-27 |
EP1778696A2 (en) | 2007-05-02 |
RU2006142705A (ru) | 2008-06-20 |
WO2005105810A3 (en) | 2006-03-02 |
DE602005005490D1 (de) | 2008-04-30 |
JP4929162B2 (ja) | 2012-05-09 |
CN1950380B (zh) | 2010-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2223921B8 (en) | 2-Thiophen-2-yl-oxazole, 2-Thiophen-2-yl-thiazole and 2-Thiophen-2-yl-1H-imidazole derivatives as antiviral agents | |
IL174467A0 (en) | Hiv replication inhibiting purine derivatives | |
ZA200705040B (en) | 2,4 (4,6) pyrimidine derivatives | |
AP2005003452A0 (en) | Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors. | |
WO2007015017A3 (fr) | Nouveaux derives de polyquinoleines et leur utilisation therapeutique | |
ZA200709689B (en) | Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and method for the preparation thereof | |
AP2321A (en) | Quinoline derivatives for use as mycobactrial inhibitor. | |
IL182121A0 (en) | Pyrimidine derivatives, processes for the preparation thereof and pharmaceutical compositions containingthe same | |
HK1093503A1 (en) | Pyrido 2, 1-a-isoquinoline derivatives as ddp-IV inhibitors | |
EP2617709B8 (en) | Guanidine derivatives as antiviral agents | |
WO2008127364A3 (en) | Antiviral compounds and use thereof | |
PL1763517T3 (pl) | Pochodne pirymidyny jako inhibitory 11BETA-HSD1 | |
IL180397A0 (en) | Diamine derivatives, fungicidal compositions containing the same, and processes for the preparation thereof | |
DK1670458T3 (da) | 1-Amino-2-oxy-substituerede tetrahydronaphthalenderivater, fremgangsmåder til fremstilling deraf og deres anvendelse som antiphlogistika | |
WO2006039250A3 (en) | Chemokine-binding heterocyclic compound salts, and methods of use thereof | |
ZA200609178B (en) | (1,10B-dihydro-2-(aminocarbonyl-phenyl)-5H-pyrazolo[1,5-c][1,3]benzoxazin-5-yl)phenylmethanone derivatives as HIV viral replication inhibitors | |
IL182739A0 (en) | Acylatednonadepsipeptides used as lysobactin derivatives | |
HK1108580A1 (en) | A process for the preparation of [1,4,5]-oxadiazepine derivatives | |
ZA200805028B (en) | Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor Xla inhibitors | |
AP2006003484A0 (en) | Nicotinamide derivatives useful as PDE4 inhibitors. | |
EP1874116A4 (en) | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR INHIBITING HIV INFECTIOUSITY | |
HK1100946A1 (en) | 1-a-HALO-2,2-DIFLUORO-2-DEOXY-D-RIBOFURANOSE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF | |
EP1781678A4 (en) | 1 -? - HALOGEN-2,2-DIFLUOR-2-DESOXY-D-RIBOFURANOSEDERIVATE AND PROCESS FOR THE PRODUCTION THEREOF | |
WO2007019126A3 (en) | Method of preparation of azaindole derivatives | |
WO2008097341A3 (en) | Antiviral compounds and use thereof |